These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28790533)

  • 1. Differential Expression of Glycolysis-Related Proteins in Follicular Neoplasms versus Hürthle Cell Neoplasms: A Retrospective Analysis.
    Kim HM; Koo JS
    Dis Markers; 2017; 2017():6230294. PubMed ID: 28790533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycolysis-related protein expression in thyroid cancer.
    Nahm JH; Kim HM; Koo JS
    Tumour Biol; 2017 Mar; 39(3):1010428317695922. PubMed ID: 28347233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Autophagy-Related Proteins in Hürthle Cell Neoplasm Is Different from That in Follicular Neoplasm.
    Cha YJ; Kim HM; Koo JS
    Dis Markers; 2017; 2017():1372387. PubMed ID: 28819333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of glutamine metabolism-related proteins in Hürthle cell neoplasm of thyroid: Comparison with follicular neoplasm.
    Cha YJ; Jang H; Koo JS
    Histol Histopathol; 2019 Feb; 34(2):167-174. PubMed ID: 30191947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of metabolism-related proteins in phyllodes tumors.
    Kwon JE; Jung WH; Koo JS
    Tumour Biol; 2013 Feb; 34(1):115-24. PubMed ID: 22986897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
    Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
    Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
    Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
    Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4.
    Pinheiro C; Miranda-Gonçalves V; Longatto-Filho A; Vicente AL; Berardinelli GN; Scapulatempo-Neto C; Costa RF; Viana CR; Reis RM; Baltazar F; Vazquez VL
    Cell Cycle; 2016 Jun; 15(11):1462-70. PubMed ID: 27105345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
    Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
    Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicompartment metabolism in papillary thyroid cancer.
    Curry JM; Tassone P; Cotzia P; Sprandio J; Luginbuhl A; Cognetti DM; Mollaee M; Domingo M; Pribitkin EA; Keane WM; Zhan TT; Birbe R; Tuluc M; Martinez-Outschoorn U
    Laryngoscope; 2016 Oct; 126(10):2410-2418. PubMed ID: 26666958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.
    Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J
    Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
    Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
    Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of Hurthle cell neoplasms by gene profiling.
    Finley DJ; Zhu B; Fahey TJ
    Surgery; 2004 Dec; 136(6):1160-8. PubMed ID: 15657571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.
    Ganly I; Ricarte Filho J; Eng S; Ghossein R; Morris LG; Liang Y; Socci N; Kannan K; Mo Q; Fagin JA; Chan TA
    J Clin Endocrinol Metab; 2013 May; 98(5):E962-72. PubMed ID: 23543667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
    Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas?
    Musholt PB; Imkamp F; von Wasielewski R; Schmid KW; Musholt TJ
    Surgery; 2003 Dec; 134(6):881-9; discussion 889. PubMed ID: 14668719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma.
    Kim S; Jung WH; Koo JS
    J Breast Cancer; 2013 Jun; 16(2):146-51. PubMed ID: 23843845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis.
    Wang Y; Li Y; Jiang L; Ren X; Cheng B; Xia J
    Aging (Albany NY); 2021 Feb; 13(5):7284-7299. PubMed ID: 33653965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAIX forms a transport metabolon with monocarboxylate transporters in human breast cancer cells.
    Ames S; Andring JT; McKenna R; Becker HM
    Oncogene; 2020 Feb; 39(8):1710-1723. PubMed ID: 31723238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
    Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
    Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.